Emergent BioSolutions (EBS) announced the expansion of its proprietary NARCANDirect online distribution network to include Kloxxado Nasal Spray 8 mg. The platform provides qualified direct purchasers, including emergency medical services, law enforcement, fire departments, government agencies, schools/universities and community-based naloxone distribution programs with streamlined access to opioid overdose response products.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent BioSolutions Secures $62.4M ASPR Contract Modification
- Emergent BioSolutions secures $62.4M contract modification for BAT
- Emergent BioSolutions announces addition to Russell 3000 Index
- Emergent BioSolutions teams up with Victoria’s Voice Foundation
- Emergent Biosolutions Settlement Receives Preliminary Approval